4.73
price down icon0.42%   -0.02
pre-market  Vorhandelsmarkt:  4.97   0.24   +5.07%
loading

Precigen Inc Aktie (PGEN) Neueste Nachrichten

pulisher
Jan 24, 2026

Zacks Research Downgrades Precigen (NASDAQ:PGEN) to Strong Sell - MarketBeat

Jan 24, 2026
pulisher
Jan 23, 2026

Precigen, Inc. (PGEN) Stock Analysis: Exploring a Potential 75% Upside in the Biotech Sector - DirectorsTalk Interviews

Jan 23, 2026
pulisher
Jan 23, 2026

Market Pulse: Is Precigen Inc stock influenced by commodity pricesJuly 2025 Setups & Free Daily Entry Point Trade Alerts - baoquankhu1.vn

Jan 23, 2026
pulisher
Jan 21, 2026

Why Precigen (PGEN) Is Up 5.3% After PAPZIMEOS Becomes First-Line RRP Standard of Care – And What's Next - simplywall.st

Jan 21, 2026
pulisher
Jan 21, 2026

Patient Capital Management LLC Grows Stake in Precigen, Inc. $PGEN - MarketBeat

Jan 21, 2026
pulisher
Jan 20, 2026

New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis - Finviz

Jan 20, 2026
pulisher
Jan 19, 2026

3 Growth Companies With High Insider Ownership And Up To 79% Earnings Growth - simplywall.st

Jan 19, 2026
pulisher
Jan 18, 2026

Precigen, Inc. (NASDAQ:PGEN) Sees Large Growth in Short Interest - MarketBeat

Jan 18, 2026
pulisher
Jan 18, 2026

Earnings Risk: Is Precigen Inc stock influenced by commodity prices2025 Price Targets & Low Volatility Stock Recommendations - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 16, 2026

Precigen (NASDAQ:PGEN) Shares Gap UpWhat's Next? - MarketBeat

Jan 16, 2026
pulisher
Jan 16, 2026

Precigen, Inc. (NASDAQ:PGEN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Jan 16, 2026
pulisher
Jan 15, 2026

Assessing Precigen (PGEN) Valuation After PAPZIMEOS Commercial Momentum And EMA Milestone - Sahm

Jan 15, 2026
pulisher
Jan 13, 2026

Is PGEN’s PAPZIMEOS Exclusivity Quietly Redefining Its Competitive Moat in Rare Disease Therapy? - simplywall.st

Jan 13, 2026
pulisher
Jan 13, 2026

Precigen reports strong adoption of RRP treatment PAPZIMEOS By Investing.com - Investing.com Nigeria

Jan 13, 2026
pulisher
Jan 12, 2026

Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference - Investing News Network

Jan 12, 2026
pulisher
Jan 12, 2026

Precigen (NASDAQ:PGEN) Trading Down 7.5%What's Next? - MarketBeat

Jan 12, 2026
pulisher
Jan 12, 2026

Precigen reports strong adoption of RRP treatment PAPZIMEOS - Investing.com

Jan 12, 2026
pulisher
Jan 12, 2026

Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com

Jan 12, 2026
pulisher
Jan 12, 2026

Iridian Asset Management LLC CT Sells 611,716 Shares of Precigen, Inc. $PGEN - MarketBeat

Jan 12, 2026
pulisher
Jan 10, 2026

Is Precigen Inc. stock a buy on dipsInsider Buying & Technical Analysis for Trade Confirmation - ulpravda.ru

Jan 10, 2026
pulisher
Jan 09, 2026

Precigen, Inc. (PGEN) Stock Analysis: Biotechnology Innovator With Potential 84% Upside - DirectorsTalk Interviews

Jan 09, 2026
pulisher
Jan 08, 2026

Can Precigen Inc. stock beat market expectations this quarterJuly 2025 Review & Fast Moving Stock Trade Plans - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Can Precigen Inc. stock double in next 5 yearsMarket Weekly Review & Fast Exit and Entry Strategy Plans - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Precigen, Inc. (NASDAQ:PGEN): Are Analysts Optimistic? - simplywall.st

Jan 08, 2026
pulisher
Jan 08, 2026

Market Sentiment Around Loss-Making Precigen, Inc. (NASDAQ:PGEN) - 富途牛牛

Jan 08, 2026
pulisher
Jan 08, 2026

Is Precigen Inc. stock a buy before product launchesMorning Star Patterns & Start Small. End Wealthy. - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Precigen Inc. stock recover faster than peersGeopolitical Risk Analysis & Amplify Gains With Picks - ulpravda.ru

Jan 08, 2026
pulisher
Jan 06, 2026

Will Precigen Inc. stock see insider buying2026 world cup usa national team quarterfinals star players possession football tactical prediction insights - ulpravda.ru

Jan 06, 2026
pulisher
Jan 05, 2026

Precigen to Present at the 44th Annual J.P. Morgan Healthcare Co - GuruFocus

Jan 05, 2026
pulisher
Jan 05, 2026

Precigen (NASDAQ:PGEN) Trading Down 6.1%What's Next? - MarketBeat

Jan 05, 2026
pulisher
Dec 30, 2025

Precigen (NASDAQ:PGEN) Trading Down 4.2%Here's What Happened - MarketBeat

Dec 30, 2025
pulisher
Dec 29, 2025

Will PGEN’s New Drug Make a Splash? - StocksToTrade

Dec 29, 2025
pulisher
Dec 29, 2025

Precigen (NASDAQ:PGEN) Shares Up 5.1%What's Next? - MarketBeat

Dec 29, 2025
pulisher
Dec 29, 2025

DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday - Benzinga

Dec 29, 2025
pulisher
Dec 23, 2025

Precigen (NASDAQ:PGEN) Shares Gap Down Following Insider Selling - MarketBeat

Dec 23, 2025
pulisher
Dec 23, 2025

Monday’s Insider Activity: Andreessen Horowitz Leads Major Buys - Investing.com

Dec 23, 2025
pulisher
Dec 23, 2025

Monday’s Insider Activity: Andreessen Horowitz Leads Major Buys By Investing.com - Investing.com UK

Dec 23, 2025
pulisher
Dec 23, 2025

Precigen Insider Sold Shares Worth $7,942,150, According to a Recent SEC Filing - marketscreener.com

Dec 23, 2025
pulisher
Dec 22, 2025

Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 1,900,036 Shares of Stock - MarketBeat

Dec 22, 2025
pulisher
Dec 22, 2025

Kirk sells Precigen shares worth $7.9 million By Investing.com - Investing.com South Africa

Dec 22, 2025
pulisher
Dec 22, 2025

Kirk sells Precigen shares worth $7.9 million - Investing.com

Dec 22, 2025
pulisher
Dec 22, 2025

Precigen, Inc. (NASDAQ:PGEN) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Dec 22, 2025
pulisher
Dec 20, 2025

Profit Review: Will Precigen Inc. stock see insider buyingInsider Selling & Real-Time Buy Signal Alerts - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Market Outlook: Is Precigen Inc. stock a buy on dipsWeekly Profit Report & Real-Time Volume Analysis - ulpravda.ru

Dec 19, 2025
pulisher
Dec 19, 2025

Precigen, Inc. (PGEN) Stock Analysis: Exploring a 103.84% Upside Potential in the Booming Biotech Sector - DirectorsTalk Interviews

Dec 19, 2025
pulisher
Dec 18, 2025

Trade Alert: Independent Director Of Precigen Jeffrey Kindler Has Sold Stock - simplywall.st

Dec 18, 2025
$99.82
price up icon 2.09%
$103.47
price up icon 0.87%
$34.40
price up icon 2.78%
$119.34
price up icon 1.14%
$162.64
price up icon 1.83%
biotechnology ONC
$336.16
price down icon 0.48%
Kapitalisierung:     |  Volumen (24h):